BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Drug Development

  Intra-Cellular Therapies, Inc. Presents New Data From The Phase 2 Clinical Trial Of ITI-007 In Schizophrenia At The 167th Annual Meeting Of The American Psychiatric Association

  May 7, 2014

   · 

  1 min read
• Pharm Country

  ConMed Corporation To Present At The 2014 Bank of America Merrill Lynch Health Care Conference

  May 7, 2014

   · 

  3 min read
• Pluristem Therapeutics To Be Added To New TA Tech-Elite Stock Index In Israel

  May 7, 2014

   · 

  1 min read
• SANUWAVE, Inc. To Present At Upcoming Financial Conferences

  May 7, 2014

   · 

  1 min read
• Business

  CombiMatrix Corporation Reports Record Revenues for 2014 First Quarter

  May 7, 2014

   · 

  1 min read
• Business

  Navidea Biopharmaceuticals Announces First Quarter 2014 Financial Results

  May 7, 2014

   · 

  1 min read
• Business

  Ariad Pharmaceuticals, Inc. Reports First Quarter 2014 Financial Results And Development Progress

  May 7, 2014

   · 

  1 min read
• Drug Development

  Boehringer Ingelheim GmbH Release: New Study To Investigate Dabigatran Etexilate For Prevention Of Recurrent Stroke In High-Risk Patients

  May 7, 2014

   · 

  1 min read
• Business

  ArQule, Inc. Reports First Quarter 2014 Financial Results

  May 7, 2014

   · 

  1 min read
• Drug Development

  CoLucid Pharmaceuticals, Inc. Announces Agreement From The FDA On A Special Protocol Assessment (SPA) For The Phase 3 Trial Of Lasmiditan In Migraine Including Patients With Risk Factors For Cardiovascular Disease

  May 7, 2014

   · 

  3 min read